Trypanosoma cruzi Infection of cultured adipocytes results in an inflammatory phenotype

Obesity

Volumn 16, Issue 9, 2008, Pages 1992-1997

  Nagajyothi, Fnu ^a   Desruisseaux, Mahalia S ^a   Thiruvur, Niranjan ^a   Weiss, Louis M ^a   Braunstein, Vicki L ^a   Albanese, Chris ^b   Teixeira, Mauro M ^c   De Almeida, Cecilia J ^d,e   Lisanti, Michael P ^d,e   Scherer, Philipp E ^f   Tanowitz, Herbert B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF GENOA   (Italy)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CAVEOLIN 1; CYTOKINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL STRAIN 3T3; CHAGAS DISEASE; ELECTRON MICROSCOPY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOBLOTTING; IMMUNOLOGY; METABOLISM; MOUSE; PARASITOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRYPANOSOMA CRUZI; ULTRASTRUCTURE; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; CAVEOLIN 1; CHAGAS DISEASE; CYTOKINES; IMMUNOBLOTTING; MICE; MICROSCOPY, ELECTRON; MITOGEN-ACTIVATED PROTEIN KINASES; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, NOTCH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRYPANOSOMA CRUZI; UP-REGULATION;

TRYPANOSOMA CRUZI;

EID: 50649088581     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.331     Document Type: Article

References (40)

1. Kirchhoff LV, Pearson RD. The emergence of Chagas disease in the United States and Canada. Curr Infect Dis Rep 2007;9:347-350.
2. Vaidian AK, Weiss LM, Tanowitz HB. Chagas' disease and AIDS. Kinetoplastid Biol Dis 2004; 3:2.
3. Huang H, Chan J, Wittner M et al. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol 1999;31:75-88.
4. Huang H, Petkova SB, Cohen AW et al. Activation of transcription factors (AP-1 and NF-κB) in murine chagasic myocarditis. Activation of transcription factors AP-1 and NF-KB in murine Chagasic myocarditis. Infect Immun 2003;71:2859-2587.
5. Teixeira MM, Gazzinelli RT, Silva JS. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 2002;18:262-265.
6. Combs TP, Nagajyothi, Mukherjee Set al. The adipocyte as an important target cell for Trypanosoma cruzi infection. J Biol Chem 2005;280:24085- 24094.
7. Desruisseaux, MS, Nagajyothi, Trujillo ME, Tanowitz HB, Scherer PE. Adipocyte, adipose tissue, and infectious disease. Infect Immun 2007;75:1086-1078.
8. Hann U, Romero IA, Cancello R et al. Human adipose cells express CD4, CXCR4, CCR5 and receptors: a new target cell type for the immunodeficiency virus-1? FASEB J 2002;16:1254-1256.
9. Pasarica M, Dhurandhar NV. Infectobesity: obesity of infectious origin. Adv Food Nutr Res 2007;52:61-102.
10. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006;55:1537-1545.
11. Rowin KS, Tanowitz HB, Wittner M, Nyguen HT, Nadal-Ginard B. Inhibition of Muscle differentiation by Trypanosoma cruzi. Proc Natl Acad Sci USA 1983;80:6390-6394.
12. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 2005;84:1341-1379.
13. Hulit J, Bash T, Fu M et al. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J Biol Chem 200;275:21203-21209.
14. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007;56:1010-1013.
15. Pajvani UB, Trujillo ME, Combs TP et al. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med 2005;11:797-803.
16. Deng J, Hua K, Caveney EJ, Takahashi N, Harp JB. Protein inhibitor of activated STAT3 inhibits adipogenic gene expression. Biochem Biophys Res Commun 2006;339:923-931.
17. CorrêSantana E, Paez-Pereda M, Theodoropoulou M et al. Hypothalamus-pituitary-adrenal axis during Trypanosoma cruzi acute infection in mice. J Neuroimmunol 2006;173, 12-22.
18. Ropert C, Gazzinelli RT. Regulatory role of Toll-like receptor 2 during infection with Trypanosoma cruzi. J Endotoxin Res 2004;10:425-430.
19. Campos MA, Gazzinelli RT. Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors. Mediators Inflamm 2004;13:139-143.
20. Hassan GS, Mukherjee S, Nagajyothi F et al. Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells. Infect Immun 2006;74:152-159.
21. Mukherjee S, Huang H, Petkova SB et al. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect Immun 2004;72:5274-5282.
22. Cohen AW, Park DS, Woodman SE et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol 2003;284: C457-C474.
23. Stahl M, Ge C, Shi S, Pestell RG, Stanley P. Notch1-induced transformation of RKE-1 cells requires up-regulation of cyclin Dl. Cancer Res 2006;66:7562-7570.
24. Sharma AM, Staels B. Review: peroxisome proliferators-activated receptor-y and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrin Metabol 2007;92:386-395.
25. Kim JY, van de Wall E, Laplante M et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007:117:2621-2637.
26. Nawrocki AR, Rajala MW, Tomas E et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 2006;281:2654-2660.
27. Yamauchi T, Kamon J, Minokoshi Yet al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8, 1288-1295.
28. Okamoto Y, Arita Y, Nishida M et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Norm Metab Res 2000;32:47-50.
29. Ouchi N, Kihara S, Arita Yet al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-KB signaling through a cAMP-dependent pathway. Circulation 2000;102:1296-1301.
30. Wang C, Pattabiraman N, Zhou J-F et al. Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation. Mol Cell Biol 2003;23:6159-6173.
31. Wang C, Pattabiraman N, Zhou JN et al. Cyclin D1 repression of peroxisome proliferator-activated receptor-y expression and transactivation. Mol Cell Biol 2003;23:6159-6173.
32. Kedzierski RM, Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 2001;41:851-876.
33. Clarke KJ, Zhong Z, Schwartz DD et al. Regulation of adiponectin secretion by endothelin-1. Biochem Biophys Res Commun 2003;312:945-949.
34. Bedi D, Clarke KJ, Dennis JC et al. Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4, 5-bisphosphate/actin- dependent-mechanism. Biochem Biophys Res Commun 2006;345:332-339.
35. Juan C-C, Chuang T-Y, Chang C-L, Huang S-W, Ho LT. Endothelin-1 regulates adiponectin gene expression and secretion in 3T3-L1 adipocytes via distinct signaling pathways. Endocrinology 2007;148:1835-1842.
36. Teder P, Noble PW. A Cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol 2000;23:7-10.
37. McCarron RM, Wang L. Stanimirovic DB, Spatz M. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett 1993;156:31-34.
38. Xiong Y, Tanaka H, Richardson JA et al. Endothelin-1 stimulates leptin production in adipocytes. J Biol Chem 2001;276:28471-28477.
39. Ferrante AW Jr. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 2007;262:408-414.
40. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-867.